Position in IONS
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$2,009,483
+$1,764,606 QoQ
Shares Held
26,761
+420.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEPHENS INC /AR/ holds $6,968,085 across 12 Biotechnology names. IONS ranks #1 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
This page
|
26,761 | $2,009,483 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,951 | $1,317,739 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
887 | $685,331 | |
| 4 | TECH |
BIO-TECHNE Corp
|
12,422 | $649,173 | |
| 5 | EXEL |
Exelixis, Inc.
|
13,634 | $584,762 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,425 | $471,489 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $324,431 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,557 | $294,518 |
All Filings in IONS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,009,483 | 26,761 | Shares | Defined | 2026-04-28 | |
| 2024-06-30 | $244,877 | 5,138 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $340,427 | 7,853 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $402,443 | 7,955 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $339,519 | 7,485 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $307,971 | 7,506 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $262,403 | 7,342 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $264,503 | 7,003 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $403,598 | 9,125 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $431,060 | 11,644 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $464,926 | 12,552 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $538,641 | 17,701 | Shares | Defined | 2022-03-07 | |
| 2021-09-30 | $709,069 | 21,141 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $1,022,699 | 25,638 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,131,013 | 25,156 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,476,202 | 26,109 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,015,335 | 21,398 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,275,186 | 21,628 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $1,054,864 | 22,311 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||